Skip to main navigation Skip to search Skip to main content

Clinical convergence of autism, schizophrenia, and Alzheimer’s disease: The case of social cognition

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

2 Scopus citations

Abstract

This chapter will first briefly review some key clinical characteristics and symptomatology of each of these diagnoses. Second, it will be suggested that the clinical convergence of these three diagnoses lies mainly in the cognitive sphere, especially in the realm of social cognition. Third, social cognition—a complex series of highly phylogenetically preserved processes that are used to interpret social interaction—will be discussed. Forth, research studies and their metaanalyses regarding impairments in social cognition—along with brain areas associated with them—will be reviewed for each of the three diagnoses. Finally the chapter will review the existing pharmacological research treatment studies—along with metaanalysis of these studies—targeting social cognitive impairments in ASD and schizophrenia, suggesting that such pharmacological treatments, based on the repurposing of existing drugs may transcend diagnostic boundaries.

Original languageEnglish
Title of host publicationNeuroprotection in Autism, Schizophrenia and Alzheimer's Disease
PublisherElsevier
Pages21-53
Number of pages33
ISBN (Electronic)9780128140376
ISBN (Print)9780128140383
DOIs
StatePublished - 1 Jan 2020
Externally publishedYes

Keywords

  • Alzheimer’s disease
  • Autism spectrum disorder
  • Schizophrenia
  • Social cognition

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Clinical convergence of autism, schizophrenia, and Alzheimer’s disease: The case of social cognition'. Together they form a unique fingerprint.

Cite this